Research

HealthExperimental drug can sharply reduce amyloid beta’s impact on Alzheimer’s

Northwestern’s NU-9 drug cuts a newly found toxic amyloid subtype and early brain inflammation, offering hope for pre-symptom Alzheimer’s care.

Joseph Shavit